Pharmafile Logo

Aqurance

Aqurance consults Life Sciences industry to empower with digital solutions their salesforce, implementing top quality technology platforms, through its strategic partnerships. Founded in September 2011, with offices in Athens and Istanbul, is the fastest growing service provider for Life Sciences in South East Europe.
We believe that the future of Pharma is evidence-based. Our mission is to provide and implement effective tools that will help industry professionals make better and more effective decisions. We aim to facilitate Pharma managers in successfully overcoming budgetary and organizational challenges by using technology and data combined.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Egiou 1 & Figaleias Athens, Bilim Sokak Sun Plaza Kat: 13 Istanbul, Greece - Turkey, 14564 - 34398
+30 210 6200 206 - +90 212 366 02 40

 Latest Content from PMHub 

Take the Multichannel Health Check

Complete the Multichannel Health Check to find out what type of marketer you are and receive expert advice on how to get to the next step.

How to prepare and execute a multichannel campaign

You may be familiar with digital marketing, however Multichannel Marketing is quite different.

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Pegasus shortlisted for ‘PM Society Digital Media Awards 2014’

Press Releases | September 5, 2014 | Inizio

Brighton-based independent healthcare specialist continues to showcase its digital expertise with shortlist nomination

Exploring MINT: Part 3 – Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

3 Steps to Navigating Multichannel in Healthcare

You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign.

Exploring MINT: Part 2 – Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Pegasus Wins ‘Consultancy of the Year’ at Communiqué Awards 2014

Press Releases | July 9, 2014 | Inizio

Pegasus, the UK’s leading independent health communications consultancy, picked up the much coveted ‘Consultancy of the Year’ award at last week’s Communiqué Awards 2014, fighting off stiff competition from the...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.